Cullen/Frost Bankers’s Repligen RGEN Stock Holding History

Cullen/Frost Bankers’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-65	Closed	-$9.67K	–	1433
2024 Q3	$9.67K	Buy	+65	New	+$9.32K	﹤0.01%	899
2024 Q1	–	Sell	-25	Closed	-$4.5K	–	1073
2023 Q4	$4.5K	Buy	+25	New	+$3.89K	﹤0.01%	881
2023 Q2	–	Sell	-45	Closed	-$7.58K	–	1248
2023 Q1	$7.58K	Buy	+45	New	+$8.03K	﹤0.01%	981
2022 Q3	–	Sell	-65	Closed	-$11K	–	1190
2022 Q2	$11K	Sell	65 -200	-75%	-$31.6K	﹤0.01%	907
2022 Q1	$50K	Hold	265	–	–	﹤0.01%	748
2021 Q4	$70K	Hold	265	–	–	﹤0.01%	694
2021 Q3	$77K	Sell	265 -200	-43%	-$51.3K	﹤0.01%	667
2021 Q2	$93K	Hold	465	–	–	﹤0.01%	655
2021 Q1	$90K	Buy	465 +65	+16%	+$13.3K	﹤0.01%	626
2020 Q4	$77K	Hold	400	–	–	﹤0.01%	616
2020 Q3	$59K	Buy	+400	New	+$57.2K	﹤0.01%	641

Other funds holding RGEN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Cullen/Frost Bankers's RGEN Position: Q4 2024 in Review

Cullen/Frost Bankers sold out of Repligen (RGEN) in Q4 2024, closing a stake of 65 shares — an estimated $9.67K sold.

Cullen/Frost Bankers first reported a position in RGEN in Q3 2020 and held it in 11 quarters. The position peaked at $93K in Q2 2021. 430 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

Cullen/Frost Bankers reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
Cullen/Frost Bankers sold 65 Repligen shares in Q4 2024, an estimated $9.67K.
Cullen/Frost Bankers first reported a position in Repligen in Q3 2020 and held it in 11 quarters.
Cullen/Frost Bankers's Repligen position peaked at $93K in Q2 2021.
430 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Cullen/Frost Bankers's 13F filing for Q4 2024, filed 6 Feb 2025.